{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:10:42Z","timestamp":1770336642385,"version":"3.49.0"},"reference-count":33,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,12,17]],"date-time":"2015-12-17T00:00:00Z","timestamp":1450310400000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">BK<\/jats:styled-content> polyomavirus (<jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>yV) viremia\/nephropathy and reduction in immunosuppression following viremia may increase the risk of alloimmune activation and allograft rejection. This study investigates the impact of <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>yV viremia on <jats:italic>de novo<\/jats:italic> donor anti\u2010human leukocyte antigen (<jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>)\u2010specific antibodies (dn<jats:styled-content style=\"fixed-case\">DSA<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and methods<\/jats:title><jats:p>All primary renal transplants at East Carolina University from March 1999 to December 2010, with at least 1 post\u2010transplant <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>yV viral load testing, were analyzed. Patients were negative for anti\u2010<jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content> antibodies to donor antigens (tested via single antigen beads) at transplantation and at first <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>yV testing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Nineteen of 174 patients (11%) tested positive for <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>yV viremia. Within 24\u00a0months of <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>yV viremia detection, 79% of <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>yV\u2010viremic patients developed dn<jats:styled-content style=\"fixed-case\">DSA<\/jats:styled-content>. Only 20% of <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>yV viremia\u2010persistent cases, compared to 86% of <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>yV viremia\u2010resolved cases, developed dn<jats:styled-content style=\"fixed-case\">DSA<\/jats:styled-content> (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.03). Poor allograft survival was evident in <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>yV viremia\u2010persistent patients (60% failure by 2\u00a0years post <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>yV diagnosis) and in <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>yV viremia\u2010resolved patients with dn<jats:styled-content style=\"fixed-case\">DSA<\/jats:styled-content> (5\u2010year post <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>yV diagnosis allograft survival of 48%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Post\u2010transplant <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>yV viremia and preemptive immunosuppression reduction is associated with high rates of dn<jats:styled-content style=\"fixed-case\">DSA<\/jats:styled-content>. When preemptively treating <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>yV viremia, dn<jats:styled-content style=\"fixed-case\">DSA<\/jats:styled-content> should be monitored to prevent allograft consequences.<\/jats:p><\/jats:sec>","DOI":"10.1111\/tid.12467","type":"journal-article","created":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T07:44:46Z","timestamp":1444203886000},"page":"848-858","source":"Crossref","is-referenced-by-count":35,"title":["Onset and progression of <i>de novo<\/i> donor\u2010specific anti\u2010human leukocyte antigen antibodies after <scp>BK<\/scp> polyomavirus and preemptive immunosuppression reduction"],"prefix":"10.1111","volume":"17","author":[{"given":"G.","family":"Dieplinger","sequence":"first","affiliation":[{"name":"Terasaki Research Institute Los Angeles California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Everly","sequence":"additional","affiliation":[{"name":"Terasaki Research Institute Los Angeles California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.P.","family":"Briley","sequence":"additional","affiliation":[{"name":"Department of Pathology Brody School of Medicine at East Carolina University Greenville North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.E.","family":"Haisch","sequence":"additional","affiliation":[{"name":"Department of Surgery Brody School of Medicine at East Carolina University Greenville North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bolin","sequence":"additional","affiliation":[{"name":"Department of Medicine Brody School of Medicine at East Carolina University Greenville North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.Q.","family":"Maldonado","sequence":"additional","affiliation":[{"name":"Vidant Medical Center Greenville North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.T.","family":"Kendrick","sequence":"additional","affiliation":[{"name":"Eastern Nephrology Associates Greenville North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.A.","family":"Kendrick","sequence":"additional","affiliation":[{"name":"Eastern Nephrology Associates Greenville North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Morgan","sequence":"additional","affiliation":[{"name":"Department of Surgery Brody School of Medicine at East Carolina University Greenville North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.I.","family":"Terasaki","sequence":"additional","affiliation":[{"name":"Terasaki Research Institute Los Angeles California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"Rebellato","sequence":"additional","affiliation":[{"name":"Department of Pathology Brody School of Medicine at East Carolina University Greenville North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,12,17]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000156165.83160.09"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2008.00342.x"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2011.00619.x"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020439"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04051206"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e318197c17d"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03840.x"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01296.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000023435.07320.81"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03310.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000269706.59977.a5"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04239.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05691207"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014121234"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182139da1"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000438196.30790.66"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31827d62e3"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04013.x"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2003.00072.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01688.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014010119"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31816a8a6d"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12731"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2014.07.022"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31823ec05a"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00742.x"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02952.x"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.12531211"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2009.00407.x"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.7.3495-3505.2006"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.01096.x"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01050308"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03930907"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftid.12467","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.12467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T15:15:13Z","timestamp":1695482113000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tid.12467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1111\/tid.12467"],"URL":"https:\/\/doi.org\/10.1111\/tid.12467","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}